Microbiome therapeutics
Auf einen Blick
- Projektleiter/in : Prof. Dr. Dieter Eibl, Dr. Florian Rosenthal
- Stellv. Projektleiter/in : Cedric Schirmer
- Projektteam : Misha Teale
- Projektvolumen : CHF 19'665
- Projektstatus : abgeschlossen
- Drittmittelgeber : Innosuisse (Innovationsprojekt / Projekt Nr. 27873.1 PFLS-LS)
- Projektpartner : PharmaBiome AG
- Kontaktperson : Dieter Eibl
Beschreibung
Development of a novel two-step process for the production of next Generation microbiome therapeutics. We will develop an innovative, two step production technology for consortia of strict anaerobic gut bacteria. This will be the first GMP grade, large scale production process in the gut microbiome field, resulting in viable, highly efficient and stable microbial products.
Publikationen
-
Rossi, Lia; Schirmer, Cedric; Teale, Misha; Kurt, Fabienne; Rosenthal, Florian; Eibl, Dieter,
2019.
Proof of concept study for cultivation of strict anaerobes in a single-use wave-mixed bioreactor [Poster].
In:
BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019.
ZHAW Zürcher Hochschule für Angewandte Wissenschaften.